Intramyocardial autologous cell engraftment in patients with ischaemic heart failure: A meta-analysis of randomised controlled trials

Heart Lung and Circulation

Volumn 22, Issue 11, 2013, Pages 887-894

  Cheng, Kang ^a   Wu, Feng ^a   Cao, Feng ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Bone marrow mononuclear cell; Heart failure; Ischaemic; Meta analysis; Myoblast

Indexed keywords

ACUTE HEART FAILURE; ARTICLE; BONE MARROW CELL; BONE MARROW MONONUCLEAR CELL; CARDIOVASCULAR RISK; CAUSE OF DEATH; CELL THERAPY; CLINICAL EFFECTIVENESS; DISEASE ASSOCIATION; EXERCISE TOLERANCE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE TACHYCARDIA; HUMAN; INTRAMYOCARDIAL AUTOLOGOUS CELL ENGRAFTMENT; ISCHEMIC HEART FAILURE; META ANALYSIS; PATIENT SAFETY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT;

BONE MARROW MONONUCLEAR CELL; HEART FAILURE; ISCHAEMIC; META-ANALYSIS; MYOBLAST;

AUTOGRAFTS; CELL- AND TISSUE-BASED THERAPY; HEART FAILURE; MEDLINE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEM CELL TRANSPLANTATION; STROKE VOLUME;

EID: 84887815847     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2013.04.112     Document Type: Article

References (28)

1. Steg P.G., James S.K., Atar D., Badano L.P., Blomstrom-Lundqvist C., Borger M.A., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 2012, 33:2569-2619.
2. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005, 112:e154-e235.
3. Durrani S., Konoplyannikov M., Ashraf M., Haider K.H. Skeletal myoblasts for cardiac repair. Regen Med 2010, 5:919-932.
4. Menasche P. Skeletal myoblasts and cardiac repair. J Mol Cell Cardiol 2008, 45:545-553.
5. van den Bos E.J., Thompson R.B., Wagner A., Mahrholdt H., Morimoto Y., Thomson L.E., et al. Functional assessment of myoblast transplantation for cardiac repair with magnetic resonance imaging. Eur J Heart Fail 2005, 7:435-443.
6. Ghostine S., Carrion C., Souza L.C., Richard P., Bruneval P., Vilquin J.T., et al. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 2002, 106(12 Suppl. 1):I131-I136.
7. McConnell P.I., del Rio C.L., Jacoby D.B., Pavlicova M., Kwiatkowski P., Zawadzka A., et al. Correlation of autologous skeletal myoblast survival with changes in left ventricular remodeling in dilated ischemic heart failure. J Thorac Cardiovasc Surg 2005, 130:1001.
8. Jain M., DerSimonian H., Brenner D.A., Ngoy S., Teller P., Edge A.S., et al. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 2001, 103:1920-1927.
9. Dib N., Michler R.E., Pagani F.D., Wright S., Kereiakes D.J., Lengerich R., et al. Safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: four-year follow-up. Circulation 2005, 112:1748-1755.
10. Menasche P., Alfieri O., Janssens S., McKenna W., Reichenspurner H., Trinquart L., et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008, 117:1189-1200.
11. Ye Z., Zhang B.L., Zhao X.X., Qin Y.W., Wu H., Cao J., et al. Intracoronary infusion of bone marrow-derived mononuclear cells contributes to longstanding improvements of left ventricular performance and remodelling after acute myocardial infarction: a meta-analysis. Heart Lung Circ 2012, 21:725-733.
12. Wen Y., Chen B., Wang C., Ma X., Gao Q. Bone marrow-derived mononuclear cell therapy for patients with ischemic heart disease and ischemic heart failure. Expert Opin Biol Ther 2012, 12:1563-1573.
13. Seeger F.H., Tonn T., Krzossok N., Zeiher A.M., Dimmeler S. Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J 2007, 28:766-772.
14. Heeschen C., Lehmann R., Honold J., Assmus B., Aicher A., Walter D.H., et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 2004, 109:1615-1622.
15. Jadad A.R., Moore R.A., Carroll D., Jenkinson C., Reynolds D.J., Gavaghan D.J., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996, 17:1-12.
16. Zhang S., Ge J., Yao K., Qian J. Meta-analysis of early versus deferred revascularization for non-ST-segment elevation acute coronary syndrome. Am J Cardiol 2011, 108:1207-1213.
17. Dib N., Dinsmore J., Lababidi Z., White B., Moravec S., Campbell A., et al. One-year follow-up of feasibility and safety of the first U.S., randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JACC Cardiovasc Interv 2009, 2:9-16.
18. Duckers H.J., Houtgraaf J., Hehrlein C., Schofer J., Waltenberger J., Gershlick A., et al. Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial. EuroIntervention 2011, 6:805-812.
19. Perin E.C., Silva G.V., Henry T.D., Cabreira-Hansen M.G., Moore W.H., Coulter S.A., et al. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). Am Heart J 2011, 161:1078-1087.
20. Povsic T.J., O'Connor C.M., Henry T., Taussig A., Kereiakes D.J., Fortuin F.D., et al. A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction. Am Heart J 2011, 162:654-662.
21. Menasche P., Hagege A.A., Scorsin M., Pouzet B., Desnos M., Duboc D., et al. Myoblast transplantation for heart failure. Lancet 2001, 357:279-280.
22. Forman D.E., Fleg J.L., Kitzman D.W., Brawner C.A., Swank A.M., McKelvie R.S., et al. 6-Minute walk test provides prognostic utility comparable to cardiopulmonary exercise testing in ambulatory outpatients with systolic heart failure. J Am Coll Cardiol 2012, 10.1016/j.jacc.2012.08.1010.
23. Heggunje P.S., Harjai K.J., Stone G.W., Mehta R.H., Marsalese D.L., Boura J.A., et al. Procedural success versus clinical risk status in determining discharge of patients after primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2004, 44:1400-1407.
24. McMurray J.J., Adamopoulos S., Anker S.D., Auricchio A., Bohm M., Dickstein K., et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 2012, 33:1787-1847.
25. Menasche P., Hagege A.A., Vilquin J.T., Desnos M., Abergel E., Pouzet B., et al. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J Am Coll Cardiol 2003, 41:1078-1083.
26. Pagani F.D., DerSimonian H., Zawadzka A., Wetzel K., Edge A.S., Jacoby D.B., et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J Am Coll Cardiol 2003, 41:879-888.
27. Pouzet B., Vilquin J.T., Hagege A.A., Scorsin M., Messas E., Fiszman M., et al. Intramyocardial transplantation of autologous myoblasts: can tissue processing be optimized?. Circulation 2000, 102(19 Suppl. 3):III210-III215.
28. Memon I.A., Sawa Y., Miyagawa S., Taketani S., Matsuda H. Combined autologous cellular cardiomyoplasty with skeletal myoblasts and bone marrow cells in canine hearts for ischemic cardiomyopathy. J Thorac Cardiovasc Surg 2005, 130:646-653.